s-nitrosoglutathione has been researched along with angiotensin ii in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chigogidze, T; Jonas, U; Kediia, G; Kediia, M; Managadze, LG; Truss, MC; Uckert, S | 1 |
Grave, K; Königshausen, E; Mori, Y; Potthoff, SA; Rump, LC; Sivritas, SH; Stamer, S; Stegbauer, J; Thieme, M; Woznowski, M | 1 |
Bouressam, ML; Dupuis, F; Gaucher, C; Lartaud, I; Lecat, S; Perrin-Sarrado, C; Raoul, A | 1 |
3 other study(ies) available for s-nitrosoglutathione and angiotensin ii
Article | Year |
---|---|
[In vitro effects of cAMP- and cGMP-stimulating drugs on the relaxation of the prostate smooth muscle tissue contraction induced by endothelin-1].
Topics: Adenylyl Cyclases; Aged; Angiotensin II; Colforsin; Cyclic AMP; Cyclic GMP; Endothelin-1; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Prostate; S-Nitrosoglutathione; Signal Transduction | 2006 |
Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Hypertension; Kidney; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Perfusion; Protein Kinase Inhibitors; S-Nitrosoglutathione; Systole; Vascular Remodeling | 2016 |
S-nitrosoglutathione inhibits cerebrovascular angiotensin II-dependent and -independent AT
Topics: Angiotensin II; Animals; Cerebral Arteries; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Ligands; Male; Nitric Oxide; Nitrosation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; S-Nitrosoglutathione; Signal Transduction; Structure-Activity Relationship | 2019 |